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Ethnopharmacological relevance: Tuberculosis (TB) caused by Mycobacterium tuberculosis remains an
ongoing threat to human health. Several medicinal plants are used traditionally to treat tuberculosis in
Ghana. The current study was designed to investigate the antimycobacterial activity and cytotoxicity of
crude extracts from ﬁve selected medicinal plants.
Material and methods: The microplate alamar blue assay (MABA) was used for antimycobacterial studies
while the CellTiter 96s AQueous Assay, which is composed of solutions of a novel tetrazolium compound
[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner
salt; MTS] and an electron coupling reagent (phenazine methosulfate) PMS, was used for cytotoxic
studies. Correlation coefﬁcients were used to compare the activity of crude extracts against non-
pathogenic strains and the pathogenic Mycobacterium tuberculosis subsp.tuberculosis.
Results: Results of the MIC determinations indicated that all the crude extracts were active on all the
three tested mycobacterial strains. Minimum inhibitory concentration values as low as 156.3 mg/mL
againstM. tuberculosis; Strain H37Ra (ATCCs 25,177™) were recorded from the leaves of Solanum torvum
Sw. (Solanaceae). Cytotoxicity of the extracts varied, and the leaves from S. torvum had the most pro-
mising selectivity index. Activity against M. tuberculosis; Strain H37Ra was the best predictor of activity
against pathogenic Mycobacterium tuberculosis subsp.tuberculosis (correlation coefﬁcient¼0.8).
Conclusion: The overall results of the present study provide supportive data on the use of some med-
icinal plants for tuberculosis treatment. The leaves of Solanum torvum are a potential source of anti-TB
natural products and deserve further investigations to develop novel anti-TB agents against sensitive and
drug resistant strains of M. tuberculosis.
& 2016 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under the CC BY
license (http://creativecommons.org/licenses/by/4.0/).1. Introduction
Mycobacterium tuberculosis, a facultative intracellular microbe
belonging to the M. tuberculosis complex, is the most important
cause of tuberculosis (TB) in humans. In addition toM. tuberculosis,
other members of the M. tuberculosis complex that are able to
cause tuberculosis in humans include Mycobacterium bovis, My-
cobacterium africanum, Mycobacterium microti and Mycobacterium
canetti (Aro et al., 2015). Tuberculosis, an old yet emerging in-
fectious disease, is one of the leading causes of human morbidity
and mortality (Nguta et al., 2015b). In the year 2013, the Worldr Ireland Ltd. This is an open acces
Health, Pharmacology and
of Nairobi, Kenya.Health Organization (WHO) reported one and half million deaths
and nine million new cases of active tuberculosis globally caused
by TB (WHO, 2014). The alarming rise of multi-drug-resistant
(MDR), extensively drug-resistant (XDR) and currently, totally
drug resistant (TDR) M. tuberculosis strains, which are difﬁcult to
control with the currently available essential antitubercular drugs
on the market, and the increased incidence of TB associated with
viral infections such as HIV, have recently complicated the che-
motherapeutics of tuberculosis (Proksch et al., 2015). Thus, the
search for new drugs with novel mechanisms of action against M.
tuberculosis is urgently needed.
Historically, natural products have proved to be the most pro-
liﬁc and diverse source of antibiotics including some of those used
for the treatment of TB. Current studies have indicated the urgent
need for the development of new, safe and efﬁcacious drugs tos article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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mycobacterial scaffolds from natural products have recently been
reported. Natural products of plant biodiversity have received
considerable attention as potential anti-TB agents since they are a
proven template for the development of new molecules against
tuberculosis. Many antitubercular compounds that may prove to
be useful leads for TB drug discovery have been derived from
medicinal plants (Nguta et al., 2015b).
Natural products, especially those from the plant biodiversity
have been less intensively investigated in the past even though
they are known to contain structurally diverse molecules, many of
which are unknown. This has prompted us to investigate Ghanaian
medicinal plants for their anti-TB activity. In this study, we ex-
amined the leaves of Solanum torvum Sw. (Solanaceae), Aloe vera
var. barbadensis (Xanthorrhoeaceae), Dissotis rotundifolia (Sm.)
Triana (Melastomataceae), Chenopodium ambrosioides L. (Amar-
anthaceae) and the rhizomes of Zingiber ofﬁcinale Roscoe (Zingi-
beraceae), all obtained from the eastern region of Ghana. These
medicinal plants have been traditionally used by Ghanaian com-
munities to treat coughs and other disease conditions with
symptoms of tuberculosis (Nguta et al., 2015a). S. torvum is a shrub
widely distributed in South India, Malaysia, China, Philippines,
Thailand, West Indies and Tropical Africa. Antimicrobial activities
of the leaf and fruit of this plant have been reported. The fruits of S.
torvum are edible and traditionally used for the treatment of ab-
scesses, jigger wounds, skin infections and athlete’s foot (Chan-
drasekhar et al., 2012). Ginger (Z. ofﬁcinale) is a medicinal plant
that has been widely used in Chinese, Ayurvedic and Tibb-Unani
herbal medicines all over the world, since antiquity, for a wide
array of unrelated ailments that include arthritis, rheumatism,
sprains, muscular aches, pains, sore throats, cramps, constipation,
indigestion, vomiting, hypertension, dementia, fever, infectious
diseases and helminthiasis (Ali et al., 2008). Aloe vera is as old as
civilization and throughout history it has been used as a popular
folk medicine. It is present in the arid regions of India and is be-
lieved to be effective in treating stomach ailments, various skin
conditions such as cuts, burns and eczema, gastrointestinal pro-
blems, skin diseases, constipation, anti-inﬂammatory effects,
wound healing, as an anti-ulcer and anti-diabetic agent. Currently
the plant is widely used in skin care, cosmetics and as a neu-
traceutical (Klein and Penneys, 1988). D. rotundifolia and C. am-
brosioides are traditionally used in Ghanaian ethnomedicine
against upper and lower respiratory tract conditions (Nguta et al.,
2015a).
All the plant species were evaluated in vitro against M.tu-
berculosis subsp.tuberculosis (ATCCs 27,294™), M. tuberculosis;
Strain H37Ra (ATCCs 25,177™) and Mycobacterium smegmatis
(ATCCs19420™) for anti-TB activity as well as against MRC-5,
human fetal lung ﬁbroblast cell lines (ATCCs CCL-171™) in order
to assess their general cytotoxicity. The study was extended to
further investigate the best predictor of activity against pathogenic
M. tuberculosis subsp.tuberculosis from the non-pathogenic strains
tested.2. Materials and methods
2.1. Antibiotics and chemicals
Isoniazid499%, (INH), rifampicin 95% (RIF) and ethambutol
hydrochloride, European pharmacopoeia (EP) reference standard
(EMB) were obtained from Sigma-Aldrich (St. Louis, Mo.). Stock
solutions at 1000 μg/mL were ﬁlter sterilized and stored at
20 °C. Working solutions were prepared at four times the ﬁnal
higher concentration in 7H9GC-Tween (Middlebrook 7H9 sup-
plemented with 0.1% casitone, 0.5% glycerol, 10% OADC (oleic acid,albumin, dextrose, and catalase); Becton-Dickinson and 0.05% (vol/
vol) Tween 80 (Sigma). The ﬁnal drug concentrations tested were
as follows: for crude extracts, 10,000 μg/mL; INH, 1.6 μg/mL; and
for RIF and EMB, 16 μg/mL. A mixture of 10X Alamar blue dye
(Alamar Biosciences/Accumed, Westlake, Ohio) and 10% Tween 80
(1:1) was sterilized by ﬁltration, and stored at 4 °C for up to
1 week.
2.2. Collection and extraction of plant Materials
The leaves of Solanum torvum, Aloe vera var. barbadensis, D.
rotundifolia, C. ambrosioides and the rhizomes of Z. ofﬁcinale were
all collected from the eastern region of Ghana during July-August
in 2014 as earlier described (Nguta et al., 2015a). The plant ma-
terials were identiﬁed at the Centre for Scientiﬁc Research into
Plant Medicine (CSRPM), Mampong-Akuapem, where voucher
specimens are deposited. The plant materials were air dried at
room temperature, ground and stored at 4 °C until use. The air
dried and powdered plant parts each weighing 100 g were ex-
tracted with 500 mls of 80% ethanol (Sigma-Aldrich, Munich,
Germany) by cold maceration at room temperature for 72 h to
yield a powder after ﬁltration and evaporation under vacuum. The
dry powder was made up to a concentration of 10,000 μg/mL in
distilled water, ﬁlter sterilized and stored at 20 °C until use.
2.3. In vitro antimycobacterial assay
2.3.1. Bacterial strains and growth conditions
Mycobacterium tuberculosis subsp.tuberculosis Mycobacterium
tuberculosis; Strain H37Ra and Mycobacterium smegmatis were
obtained from the American Type Culture Collection (Manassas,
VA 20,108, USA). They were maintained on Lowenstein-Jensen (LJ)
slopes and cultured on Middlebrook 7H9 broth (Difco, Detroit,
Mich.) supplemented with 0.2% (vol/vol) glycerol (Sigma Chemical
Co., Saint Louis, Mo.), 1.0 g of casitone (Difco) per liter, 10% (vol/vol)
OADC (oleic acid, albumin, dextrose, catalase; Difco) and 0.05%
(vol/vol) Tween 80 (Sigma). The complete medium was referred to
as 7H9GC-Tween. Cultures were grown aerobically on 7H9GC-
Tween at 37 °C.
2.3.2. Microplate alamar blue assay (MABA)
Mycobacterial strains were freshly sub cultured on LJ medium.
The inoculum was prepared in 7H9GC-Tween broth, adjusted
spectrophotometrically to a no. 1 McFarland tube standard, and
further diluted 1:10 in 7H9GC-Tween broth for the test (Palomino
et al., 2002).
The microplate alamar blue assay was carried out as described
by Palomino et al. (2002). Brieﬂy, 100 μL of 7H9GC-Tween broth
was dispensed in each well of a sterile ﬂat-bottom 96-well plate,
and serial twofold dilutions of the crude extracts and each positive
control drug were prepared directly in the plate. One hundred
microliters of inoculum was added to each well. A growth control
and a sterile control were also included for each mycobacterial
strain. Sterile water was added to all perimeter wells to avoid
evaporation during the incubation. The plates were covered,
sealed in plastic bags, and incubated at 37 °C under a normal at-
mosphere. After 48 h of incubation for M. smegmatis and 7 days of
incubation for M. tuberculosis H37Ra and M. tuberculosis subsp.
tuberculosis, 30 μL of a mixture of alamar blue solution and 10%
tween 80 (1:1) was added to each well, and the plate was re-
incubated overnight. A change in color from blue to pink indicated
the growth of bacteria, and the minimum inhibitory concentration
(MIC) was deﬁned as the lowest concentration of the crude extract
or positive control drug that prevented this change in color. The
crude extract and drug concentration ranges used were as follows:
for crude extracts, 10,000 to 19.5 μg/mL, INH, 0.025 to 1.6 μg/mL
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In vitro assay reagents were purchased from Promega (USA),
Sigma (USA) and Gibco (USA).
2.4.2. Human fetal lung ﬁbroblasts and culture conditions
MRC-5, human fetal lung ﬁbroblast cell line was obtained from
the American Type Culture Collection (Manassas, VA 20108, USA).
All cultures were maintained in a phenol red free culture medium
DMEM/F12 (Dulbecco’s modiﬁed essential medium/Ham’s 12 nu-
trient mixture, Gibco), supplemented with 5% (vol/vol) fetal calf
serum (JS Bioscience, Australia), and 1% (vol/vol) antibiotic (2 mM
L-glutamine, 100 U/mL Penicillin and 100 μg/mL Streptomycin;
Gibco). Cultured cells were kept at 37 °C in a humidiﬁed 5% carbon
dioxide (CO2) incubator. Once the cells reached conﬂuence, the
culture medium was removed from the ﬂask and the cells were
rinsed three times with sterile HBSS (Hank’s Balanced Salt Solu-
tion, Gibco). The conﬂuent cell layers were enzymatically re-
moved, using Trypsin/EDTA (Gibco, USA), and resuspended in
culture medium. Cell viability was assessed by vital staining with
trypan blue (0.4% (wt/vol); Sigma, USA), and cell numbers were
determined using a light microscope (Leitz Wetzlar, Germany).
2.4.3. Preparation of crude extracts
Crude extracts were individually suspended in the culture
medium at the concentration of 10 000 μg/mL and dispersed by
ultrasonic vibration for 15 min. In order to ensure uniform sus-
pension, they were stirred on vortex agitation (1 min) before every
use.
2.4.4. Colorimetric MTS (3-(4, 5-dimethylthiazol2-yl)-5-(3-car-
boxymethoxyphenyl)-2-(4-sulfophenyl)-2H tetrazolium) in vitro
assay
Cytotoxicity testing was performed using the Promega CellTiter
96 AQueous Non-Radioactive Cell Proliferation (MTS) assay to
determine the number of viable cells in culture (Promega, 2005).
The protocol for evaluation of cytotoxicity was adopted from
previously published papers and manufacturer’s instructions (Ba-
kand et al., 2005a, 2005b; Hayes et al., 2007). Crude extracts were
suspended in culture media, serially diluted across 96-well mi-
crotiter plates (100 μL), and incubated at 37 °C with 5% CO2 for
24 h in a humidiﬁed carbon dioxide incubator. Four hours prior to
the end of each exposure period, an MTS mixture (20 μL/well) was
added. After the completion of exposure period, the plates were
then placed on an Inﬁnite M200 Pro™ plate reader (Tecan, Austria,Table 1
Minimum inhibitory concentration (MIC in mg/mL) values of hydro-ethanolic extracts fr
Plant species/family/voucher specimen number Part used
Solanum torvum SW./ Solanaceae/JM01 Leaves
Zingiber ofﬁcinale roscoe/Zingiberaceae/JM02 Rhizomes
Aloe vera var. barbadensis/Xanthorrhoeaceae/JM03 Leaves
Dissotis rotundifolia (Sm.) Triana/Melastomataceae/JM04 Leaves




Experiments were carried out in triplicate and results are expressed as means of thre
Essential anti-tb drugs were prepared according to manufacturer’s instructions. Tested
range for positive control drugs: INH: 0.025–1.6 mg/mL; RIF: 0.25–16 mg/mL; EMB: 0.25–GmbH), shaken for ten seconds and the absorbance of the for-
mazan product was read at 490 nm. Each experiment was re-
peated on three separate occasions. Two internal controls were set
up for each experiment: (1) an IC0 consisting of cells only and (2)
IC100 consisting of medium only. Background absorbance due to
the non-speciﬁc reaction between crude extracts and the MTS
reagent was deducted from exposed cell values (Hayes and Mar-
kovic, 2002).
2.4.5. Dose response curves of in vitro cytotoxicity data
Dose response curves were plotted for the crude extracts after
correction by subtracting the background absorbance from the
controls. The percentage inhibition (%I) was determined using the
formula:
= [ × ( − )I% 100 1 At/Ac
where (At) is the absorbance of treated well and (Ac) is the ab-
sorbance of control well. CC50 value is the concentration of sample
required to inhibit 50% of the cell proliferation and was calculated
from a calibration curve by a linear regression (Joshi et al., 2010)
using Microsoft Excel. The selective index was determined as the
ratio CC50/MIC value.3. Results and discussion
In the present study, we examined the in vitro anti-
mycobacterial activity of the leaves of Solanum torvum Aloe vera
var. barbadensis, Dissotis rotundifolia, Chenopodium ambrosioides
and the rhizomes of Zingiber ofﬁcinale Roscoe against slow grow-
ing pathogenic Mycobacterium tuberculosis subsp.tuberculosis, slow
growing non-pathogenicMycobacterium tuberculosis; Strain H37Ra
and fast growing non-pathogenic Mycobacterium smegmatis. The
results of the minimum inhibitory concentration (MIC) values of
the crude extracts are shown in Table 1 below. In the present
study, the leaves from S. torvum displayed the best in vitro activity
against all the mycobacterial strains tested (Table 1).
The cytotoxic potential of the crude plant extracts were also
evaluated against MRC-5 human fetal lung ﬁbroblast cell line. The
median cytotoxic concentration (CC50 in μg/mL) determinations
and selectivity indices (SI) are shown in Table 2 below. S. torvum
leaves had the highest CC50 value and the best SI index of 31.25
(Table 2).
The present study was further extended to assess the best
predictor of activity against pathogenic M. tuberculosis amongst
the non-pathogenic mycobacterial strains used in the current
study. The correlation coefﬁcients (r) values obtained are pre-
sented in Table 3. M. tuberculosis; strain H37Ra was the best pre-
dictor of activity against the pathogenic M. tuberculosis (correla-
tion coefﬁcient¼0.7723) (Table 3).om selected medicinal plants.









e replicate experiments. All the crude extracts were dissolved in distilled water.
concentration range for crude extracts: 19.5–10,000 mg/mL; tested concentration
16 mg/mL. (-): pure compounds tested.
Table 2
Cytotoxicity (CC50 in mg/mL) of crude extracts in MRC-5 lung ﬁbroblast cells and selectivity index (SI) values in the three tested Mycobacterial strains.
Plant species/family CC50 Selectivity index (SI) values
M. smegmatis M. tb; strain H37Ra M. tb H37Rv
Solanum torvum SW./Solanaceae 31,250 12.5 199.94 25
Zingiber ofﬁcinale roscoe/Zingiberaceae 3500 0.35 1.4 0.35
Aloe vera var. barbadensis/Xanthorrhoeaceae 3200 0.32 1.28 0.64
Dissotis rotundifolia (Sm.) Triana/Melastomataceae 600 0.06 nd(MIC410) 0.12
Chenopodium ambrosioides L./Amaranthaceae 4800 0.48 0.96 nd (MIC410)
Isoniazid 12.5 6.25 156.25 416.7
Experiments were carried out in triplicate and results are expressed as means of three replicate experiments. All the crude extracts were dissolved in distilled water. nd: not
determined; MIC410,000 mg/mL: crude extracts were not active at up to 10,000 mg/mL. Voucher specimen numbers are indicated in Table 1.
Table 3
Pearson’s correlation coefﬁcients (r) between MIC values of the three mycobacter-
ium strains used.
Ms M. tb H37Ra M. tbH37Rv
Ms 1
M. tb H37Ra 0.9759 1
M. tbH37Rv 0.7698 0.7723 1
Ms: Mycobacterium smegmatis; M. tb H37Ra: Mycobacterium tuberculosis; Strain
H37Ra; M. tbH37Rv: Mycobacterium tuberculosis subsp.tuberculosis Values in bold
indicate the correlation between the non-pathogenic Mycobacterial strains and the
pathogenic Mycobacterium tuberculosis subsp.tuberculosis.
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basis of susceptibility tests that produce minimum inhibitory
concentrations (MICs) in the range of 100 to 1000 mg/mL (Kuete,
2010). Activity of crude extracts is considered to be signiﬁcant if
MIC values are below 100 mg/mL, moderate when
100oMICo625 mg/mL or low when MIC4625 mg/mL (Kuete,
2010). Therefore, the activity recorded from the leaves of S. torvum
of 156.3 mg/mL against M. tuberculosis; strain H37Ra can be con-
sidered to be moderate. Alternative criteria has been described by
Fabry et al. (1998), which consider extracts having MIC values
below 8000 mg/mL to have noteworthy antimicrobial activity. Un-
der these less stringent criteria, and considering the fact that the
medicinal plants tested in the current study are used traditionally
to treat upper and lower respiratory tract related conditions, the
activity recorded from the tested crude extracts could be con-
sidered important.
The leaves of Solanum torvum are used in Ghanaian ethnome-
dicine to treat coughs and tuberculosis (Nguta et al., 2015a). The
current study has observed moderate in vitro antimycobacterial
activity from the leaves of S. torvum against the slow growing
nonpathogenic mycobacterial strain, M. tuberculosis; strain H37Ra.
Interestingly, the leaves also inhibited the growth of the patho-
genic M. tuberculosis strain at 1250 mg/mL. These ﬁndings validate
in part the ethnoparmacological use of the leaves by local com-
munities in the eastern and greater regions of Accra to treat dis-
ease conditions whose symptoms closely resemble tuberculosis,
and hence the local communities can be trusted with the in-
formation they shared with us in the course of the study. The
current data provides evidence that the screened leaves are a
potential source of molecules against tuberculosis. Moderate an-
timycobacterial activity against the pathogenic laboratory re-
ference strain H37Rv by hydromethanolic fruit extracts from S.
torvum has been reported in Malaysia (Mohamad et al., 2011),
further supporting current ﬁndings, while adding more weight to
the ethnopharmacological utilization of the leaves in traditional
medicinal systems. It is worth noting that, the extracts in the
current study were hydroethanolic in nature, suggesting that the
phytoconstituents responsible for the antimycobacterial activityfrom both the leaves and the fruits of S. torvum are possibly in the
hydroethanolic fraction. These observations from different geo-
graphical zones render more support to the ethnobotanical use of
different parts of S. torvum in management of tuberculosis and call
for intensiﬁed studies focusing on isolation and elucidation of anti-
tb bioactive constituents from the medicinal plant. Antimicrobial
activities of the leaf and fruit of this plant have been reported
(Ajaiyeoba, 1999; Wiart et al., 2004), supporting observations from
the current study. Methy caffeate, isolated from the unripe fruits of
S. torvum inhibited the growth of M. tuberculosis (H37Rv) at a dose
of 8 μg/mL (Chandrasekhar et al., 2012), making the compound a
potential target for drug development against M. tuberculosis. This
report further supports the antimycobacterial potential of S. tor-
vum, throwing more weight to the current ﬁndings and calling for
more studies aimed at developing a new class of drugs against
tuberculosis from different parts of S. torvum. To the best of our
knowledge, the antimycobacterial activity from the leaves of S.
torvum is reported for the ﬁrst time by the current study. The
hydroethanolic extract from the leaves of S. torvum was found to
be safe in MRC-5 fetal ﬁbroblast lung cells, with a wide margin of
safety as indicated by the observed selectivity index (SI) (Table 2),
thus supporting the traditional use of the leaves for the manage-
ment of lower respiratory tract conditions. The observed wide
therapeutic window further supports the urgent need for more
studies aimed at identifying a safe and efﬁcacious novel class of
compounds with activity against the pathogenic M. tuberculosis.
The cytotoxic effects of two compounds (Solanolactosdie A, Sola-
nolactoside B) isolated from the aerial parts of S. torvum were not
signiﬁcant (Zubaida et al., 2013), supporting the safety ﬁndings
from the leaves of S. torvum observed in the current study. Further
bioassay guided studies are ongoing in our laboratories, with the
aim of isolating and elucidating the structure of bioactive mole-
cules from the leaves of S. torvum.
The rhizomes of Z. ofﬁcinale are traditionally used to treat
coughs and related lower respiratory tract conditions by the local
communities of eastern and greater regions of Ghana (Nguta et al.,
2015a). The observed inhibitory effects, is a validation to the
medicinal value of the rhizomes from Z. ofﬁcinale. Ginger (Z. ofﬁ-
cinale) extract (10 mg/kg) administered intraperitoneally has been
shown to possess a dose-dependent antimicrobial activity against
Pseudomonas aeruginosa, Salmonella typhimurium, E. coli and Can-
dida albicans. In addition, out of 29 plant extracts screened, ginger
extract was found to have the broadest range of anti-fungal ac-
tivity measured either by the fungi inhibited or as the average
diameter of the zones of inhibition and was the only crude extract
that was active against Rhizopus sp., an organism that was not
inhibited by any of the other plant extracts tested or by the anti-
fungal agent ketoconazole or berberine (Ali et al., 2008). This ob-
servations are in agreement with the current ﬁndings since the
crude extract was able to inhibit the growth of the non-pathogenic
mycobacterial strain, M. tuberculosis strain H37Ra at a dose of
J.M. Nguta et al. / Journal of Ethnopharmacology 182 (2016) 10–15142500 mg/mL. It is plausible to hypothesize that the low activity
recorded in the present study could be due to the presence of the
bioactive antimycobacterial compounds in low concentrations
from the investigated rhizomes. Furthermore, the rhizomes are
used as decoctions or concoctions in traditional medicinal systems.
The observed toxicity and low selectivity index is a pointer that Z.
ofﬁcinale may not be a safe medicinal plant for use against tu-
berculosis. The hydroethanolic leaf extract from A. vera inhibited
the growth of Mycobacterium tuberculosis subsp.tuberculosis, M.
tuberculosis; strain H37Ra and M. smegmatis at MIC values of
10,000, 2500 and 5000 mg/mL respectively. The antimycobacterial
potential of the leaves of A. vera is supported by earlier observa-
tions of antimycobacterial activity (Gupta et al., 2010) against
multi-drug resistant (MDR) strains and laboratory reference strain
H37Rv while screening aqueous extracts of Aloe vera using Low-
enstein–Jensen medium and Middlebroook 7H9 broth. However,
the high cytotoxicity against MRC-5 ﬁbroblast cell line and low
selectivity index is a signal to the fact that the investigated crude
extract may not be safe for use as a remedy against tuberculosis.
The leaves of D. rotundifolia are traditionally used by different
Ghanaian communities to treat coughs and lower respiratory tract
conditions. The observed antimycobacterial activity against pa-
thogenic Mycobacterium tuberculosis subsp.tuberculosis and non-
pathogenic M. smegmatis at MIC values of 10,000 and 5000 mg/mL
respectively validates the ethnopharmacological use of the plant
by the Ghanaian communities. However, the leaves may not make
safe preparations against tuberculosis since they have a narrow
therapeutic window and are highly toxic to the MRC-5 cell line,
calling for further studies to evaluate their in vivo toxicity. To the
best of our knowledge, the present study reports for the ﬁrst time
the in vitro antimycobacterial activity and cytotoxicity of D. ro-
tundifolia. Chenopodium ambrosoides leaves are commonly used
against chronic coughs and related low respiratory tract conditions
in Ghanaian ethnomedicine (Nguta et al., 2015a), hence the cur-
rent observations validates the ethnopharmacological use of the
said plant. In the current study, hydroethanolic extracts from the
leaves inhibited Mycobacterium tuberculosis subsp.tuberculosis and
M. tuberculosis; strain H37Ra at MIC values of 10,000 and
5000 mg/mL respectively. The current ﬁndings are in agreement
with earlier observations of in vitro antimycobacterial activity of
acetonic leaf extracts against drug sensitive and resistant strains of
M. tuberculosis (Lall and Meyer, 1999). The cytotoxic activity ex-
hibited against the MRC-5 cell line calls for further in vivo eva-
luation of the leaves for safety. Majority of natural product re-
search scientists with interests in anti-tb drug discovery have no
access to a BSL-3 laboratory (Nguta et al., 2015b), hence the search
for a non-pathogenic mycobacterial strain with a similar drug
susceptibility proﬁle similar to that of the pathogenic M. tubercu-
losis is a priority. Such information will enable scientists in la-
boratories without a BSL-3 facility to equally contribute to drug
discovery efforts against tuberculosis. The current study observed
M. tuberculosis; strain H37Ra to be the best predictor of activity of
the evaluated crude extracts against the pathogenic Mycobacter-
ium tuberculosis subsp.tuberculosis, hence could be used in a BSL-2
laboratory to investigate natural products for activity against the
pathogenic M. tuberculosis.4. Conclusion
The results from the present study are quite exciting, taking
into consideration the medical importance of the studied myco-
bacterial strains. The observed results justify the screening of
medicinal plants traditionally used against respiratory tractconditions to ﬁnd a cure against tuberculosis. These data provides
evidence that the hydroethanolic (80% ethanol) leaf extract from
the leaves of Solanum torvum have moderate activity against the
tested mycobacterial strains and a potential cure for tuberculosis.
Hence further bioassay guided studies are ongoing in our labora-
tories with an aim of isolating an efﬁcacious and a safe anti-
mycobacterial compound.Acknowledgements
Authors are thankful to the Bill and Melinda Gates Foundation
(BMGF), United States, Grant No. OP52155, for funding the study
through Noguchi Memorial Institute for Medical Research post-
doctoral program on infectious diseases. We also acknowledge Mr.
Heron Blogogyee of Centre for Scientiﬁc Research into Plant
Medicine (CSRPM-Mampong) for assistance in plant collection,
identiﬁcation and preparation.References
Aro, A.O., Dzoyem, J.P., Hlokwe, T.M., Eloff, J.N., McGaw, L.J., 2015. Some South
African rubiaceae tree leaf extracts have antimycobacterial activity against
pathogenic and non-pathogenic mycobacterium species. Phytother. Res. http://
dx.doi.org/10.1002/ptr.5338.
Ajaiyeoba, E.O., 1999. Comparative phytochemical and antimicrobial study of So-
lanum macrocarpum and Solanum torvum leaves. Fitoterapia 70, 184–186.
Ali, B.H., Blunden, G., Tanira, M.O., Nemmar, A., 2008. Some phytochemical, phar-
macological and toxicological properties of ginger (Zingiber ofﬁcinale Roscoe): a
review of recent research. Food Chem. Toxicol. 46, 409–420.
Bakand, S., Hayes, A., Winder, C., Khalil, C., Markovic, B., 2005a. In vitro cytotoxicity
testing of airborne formaldehyde collected in serum-free culture media. Tox-
icol. Ind. Health 21, 147–154.
Bakand, S., Winder, C., Khalil, C., Hayes, A., 2005b. Toxicity assessment of industrial
chemicals and airborne contaminants: transition from in vivo to in vitro test
methods: A review. Inhal. Toxicol. 17, 775–787.
Chandrasekhar, B., Veeramuthu, D., Naif, A.A., Balakrishna, K., Nitin, P.K., Vikrant, S.
R., Inshad, A.K., Savarimuthu, I., 2012. Antimicrobial and antimycobacterial
activities of methyl caffeate isolated from Solanum torvum Swartz fruit. Indian J.
Microbiol. 52 (4), 676–681.
Fabry, W., Okemo, P.O., Ansorg, R., 1998. Antibacterial activity of East African
medicinal plants. J. Ethnopharmacol. 60, 79–84.
Gupta, R., Thakur, B., Singh, P., Singh, H.B., Sharma, V.D., Katoch, V.M., 2010. Anti-
tuberculosis activity of selected medicinal plants against multi-drug resistant
Mycobacterium tuberculosis isolates. Indian J. Med. Res. 131, 809–813.
Hayes, A.J., Markovic, B., 2002. Toxicity of Australian essential oil Backhousia ci-
triodora (lemon myrtle). part 1. antimicrobial activity and in vitro cytotoxicity.
Food Chem. Toxicol. 40, 535–543.
Hayes, A., Bakand, S., Winder, C., 2007. Marx, U., Sandig, V. (Eds.), Novel in-vitro
exposure techniques for toxicity testing and biomonitoring of airborne con-
taminants, in drug testing In vitro: Breakthroughs And Trends in cell culture
technology. Wiley-VCH, Berlin, pp. 103–124.
Joshi, S.C., Verma, A.R., Mathela, C.S., 2010. Antioxidant and antibacterial activities
of the leaf essential oils of Himalayan Lauraceae species. Food Chem. Toxicol.
48, 37–40.
Klein, A.D., Penneys, N.S., 1988. Aloe vera. J. Am. Acad. Dermatol. 18 (1), 714–720.
Kuete, V., 2010. Potential of Cameroonian plants and derived products against
microbial infections: a review. Planta Med. 76, 1479–1491.
Lall, N., Meyer, J.J.M., 1999. In vitro inhibition of drug-resistant and drug-sensitive
strains of Mycobacterium tuberculosis by ethnobotanically selected South Afri-
can plants. J. Ethnopharmacol. 66, 347–354.
Mohamad, S., Zin, N.M., Wahab, H.A., Ibrahim, P., Sulaiman, S.F., Zahariluddin, A.S.
M., 2011. Antituberculosis potential of some ethnobotanically selected Malay-
sian plants. J. Ethnopharmacol. 133, 1021–1026.
Nguta, J.M., Regina, A.O., Nyarko, A.K., Manu, D.Y., Addo, P.G.A., 2015b. Current
perspectives in drug discovery against tuberculosis from natural products. Int. J.
Mycobacteriol. 4, 165–183.
Nguta, J.M., Regina, A.O., Nyarko, A.K., Manu, D.Y., Addo, P.G.A., 2015a. Medicinal
plants used to treat TB in Ghana. Int. J. Mycobacteriol 4, 116–123.
Palomino, J.C., Martin, A., Camacho, M., Guerra, H., Swings, J., Portaels, F., 2002.
Resazurin microtiter assay plate: simple and inexpensive method for detection
of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Che-
mother. 46, 2720–2722.
Proksch, P., Georgios, D., Rainer, K., Hendrik, K., Rudolf, H., Nicole, J., Victor, W.,
Wenhan, L., 2015. Callyaerins from the marine sponge Callyspongia aerizusa:
J.M. Nguta et al. / Journal of Ethnopharmacology 182 (2016) 10–15 15cyclic peptides with antitubercular activity. J. Nat. Prod. . http://dx.doi.org/
10.1021/acs.jnatprod.5b00266
Promega, 2005. CellTiter 96s Aqueous Non-Radioactive Cell Proliferation Assay,
Technical Bulletin #TB169, Revised 4/05. Promega Corporation, Madison, USA.
WHO, 2014. Global Tuberculosis Report 2014, 〈http://www.who.int/tdr/news/2014/
global-TB-report/en/〉.Wiart, C., Mogana, S., Califa, S., Mahan, M., Ismael, S., Bucle, M., Narayana, A.K.,
Sulaiman, M., 2004. Antimicrobial screening of plants used for traditional
medicine in the state of Perak, peninsular Malaysia. Fitoterapia 75 (1), 68–73.
Zubaida, Y., Ying, Y.W., Elias, B., 2013. Phytochemistry and pharmacological studies
on Solanum torvum Swartz. J. Appl. Pharm. Sci. 3 (04), 152–160.
